FDA Inspection 1334130 — HEMO BIOSCIENCE INC

HEMO BIOSCIENCE INC — FEI 3017237798

The FDA completed an inspection of HEMO BIOSCIENCE INC on Jul 30, 2026 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 30, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Durham, NC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.